2nd Dec 2021 7:02 am |
RNS |
Sotrovimab retains its activity vs Omicron variant |
1st Dec 2021 11:05 am |
PRN |
Total Voting Rights |
24th Nov 2021 4:17 pm |
RNS |
Director/PDMR Shareholding |
24th Nov 2021 4:00 pm |
RNS |
GSK publishes provisional 2022 dividend dates |
23rd Nov 2021 3:06 pm |
RNS |
Director/PDMR Shareholding |
17th Nov 2021 7:00 am |
RNS |
Nucala approved in Europe for more indications |
15th Nov 2021 4:37 pm |
RNS |
Block listing Interim Review |
12th Nov 2021 12:00 pm |
RNS |
Phase III IM administration data for sotrovimab |
12th Nov 2021 9:23 am |
RNS |
Director/PDMR Shareholding |
10th Nov 2021 11:28 am |
RNS |
Director/PDMR Shareholding |
5th Nov 2021 5:33 pm |
RNS |
GSK shares positive Phase III data for daprodustat |
1st Nov 2021 5:11 pm |
RNS |
Total Voting Rights |
27th Oct 2021 2:23 pm |
RNS |
Director/PDMR Shareholding |
27th Oct 2021 12:00 pm |
RNS |
3rd Quarter Results |
27th Oct 2021 9:00 am |
RNS |
Directorate Change |
15th Oct 2021 2:41 pm |
RNS |
Director/PDMR Shareholding |
14th Oct 2021 4:31 pm |
RNS |
Director/PDMR Shareholding |
14th Oct 2021 4:28 pm |
RNS |
Director/PDMR Shareholding |
13th Oct 2021 1:55 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2021 3:17 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2021 1:36 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2021 1:33 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2021 1:30 pm |
RNS |
Director/PDMR Shareholding |
12th Oct 2021 1:28 pm |
RNS |
Director/PDMR Shareholding |
1st Oct 2021 11:54 am |
RNS |
Total Voting Rights |
24th Sep 2021 5:28 pm |
RNS |
Director/PDMR Shareholding |
22nd Sep 2021 3:58 pm |
RNS |
Director/PDMR Shareholding |
20th Sep 2021 2:42 pm |
RNS |
Director Declaration |
13th Sep 2021 5:26 pm |
RNS |
Director/PDMR Shareholding |
9th Sep 2021 4:42 pm |
RNS |
Director/PDMR Shareholding |
7th Sep 2021 4:54 pm |
RNS |
Director/PDMR Shareholding |
3rd Sep 2021 9:32 am |
RNS |
Director/PDMR Shareholding |
1st Sep 2021 11:44 am |
RNS |
Total Voting Rights |
31st Aug 2021 7:00 am |
RNS |
SK bio & GSK start Ph3 Covid-19 vaccine trial |
25th Aug 2021 2:01 pm |
RNS |
Director/PDMR Shareholding |
23rd Aug 2021 4:39 pm |
RNS |
Director/PDMR Shareholding |
13th Aug 2021 9:38 am |
RNS |
Director/PDMR Shareholding - amendment |
11th Aug 2021 2:18 pm |
RNS |
Director/PDMR Shareholding |
11th Aug 2021 12:34 pm |
RNS |
Director/PDMR Shareholding |
5th Aug 2021 9:00 am |
RNS |
Block Listing Application |